01.07.13 | By Grady Forrer

The start of the year is always a time to think about both what can be accomplished as well as the challenges ahead. That’s what PhRMA president & CEO John Castellani does in the most recent issues of Chain Drug Review.

However, Castellani wants to think longer-term. While acknowledging a number of immediate challenges confronting America’s biopharmaceutical research industry, Castellani writes:

“…it is time to look beyond on-year or even 10-year time frames.  With due respect to the “Year Ahead” convention, policy advocates and lawmakers must take a longer view of biopharmaceutical innovation and its value for patients, our health system and our economy.”

Take a look.